Ikena Oncology, Inc. IKNA
Set alert
17.16 0.00 0.00%
At close · Jul 25
1.36 Day range 17.16
1.22 52-week range 2.29
- Open
- 1.38
- Prev close
- 17.16
- Mkt cap
- 80.59M
- Vol
- 457.26K
- Avg vol
- 72.44K
- EPS
- -1.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.36
- High
- 17.16
- Forward P/E
- -1.96
- Beta
- 0.48
- Short ratio
- 1.23
- Inst. own
- 63.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.69
- 200-d avg
- 1.60
- 1y target
- 3.00
Financial health
Altman Z-Score
42.17 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.8×
FY 2018 5y median -16.8× FY 2025
P/S 0.0×
FY 2018 5y median 74.0× FY 2025
P/B 1.2×
FY 2018 5y median 7.5× FY 2025
P/FCF -1.9×
FY 2018 5y median -15.3× FY 2025
EV/EBITDA 178×
FY 2018 5y median -15.7× FY 2025
EV/Sales 0.0×
FY 2018 5y median 70.5× FY 2025
FCF Yield -51.3%
FY 2018 5y median -6.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median -110.2% FY 2025
Net Margin 0.0%
FY 2018 5y median -110.1% FY 2025
ROE -69.1%
FY 2018 5y median -40.2% FY 2025
ROIC -58.5%
FY 2018 5y median -41.5% FY 2025
ROA -63.3%
FY 2018 5y median -35.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 11.2%
FY 2018 FY 2025
EPS (diluted) 100.0%
FY 2018 FY 2025
Free Cash Flow -4.0%
FY 2018 FY 2025
Financial Health
Current Ratio 0.0×
FY 2018 5y median 8.7× FY 2025
Quick Ratio 0.0×
FY 2018 5y median 8.7× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -107×
FY 2018 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31